SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is experiencing extreme volatility and massive trading volume following news that Madryn Asset Management acquired a 91% stake, with discussions around potential delisting. The community is fiercely debating between a short squeeze fueled by the significantly reduced float and warnings of imminent dilution or a discounted private buyout for existing shareholders.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing a surge in attention following a series of significant positive clinical trial updates across its CAR-NK lymphoma and ANKTIVA bladder cancer programs, alongside expanding global approvals, notably in Saudi Arabia. The community is buzzing with bullish sentiment, highlighting record trading volume and anticipation of a short squeeze, driven by the belief that the company's innovative cancer treatments represent a major disruption to the biotechnology sector.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk (TTD) is experiencing a significant downturn, consistently hitting new multi-year lows that have fueled widespread community frustration and calls for CEO Jeff Green's accountability. The stock's underperformance, even on broader market up days, is drawing intense debate between investors concerned about competition from "walled gardens" and those with long-term conviction in the company's fundamentals and future growth in connected TV. Upcoming earnings are highly anticipated as a potential catalyst to either validate bearish sentiment or trigger a rebound.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is experiencing significant volatility and a notable price decline, generating intense community discussion despite a wave of recent analyst upgrades and bullish outlooks. Investors are actively debating whether the sharp pullback is due to broader tech sector weakness, option-related manipulation, or a fundamental re-evaluation, with many buying the dip while others anticipate further downside.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is trending due to a sharp, prolonged selloff since its IPO, leading to widespread investor frustration and substantial losses. The community is actively discussing impending lockup expirations and perceived aggressive insider selling as key drivers for the sustained downward pressure. This performance is amplified by broader concerns within the software sector and evolving debates around AI's impact on design tools.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is trending due to excitement surrounding its robust partnerships, most notably with World Liberty Finance for USD1 payroll integration and ongoing discussions for Stellar and Ripple collaborations. The community views ZBCN as an undervalued 'hidden gem,' anticipating significant growth from its ISO 20022 compliance, upcoming Super App launch, and a shift towards a deflationary token model, with many 'pirates' accumulating for long-term gains.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing a notable surge, driven by substantial trading volume and a strong rebound that the community attributes to aggressive short covering. Many traders are celebrating the stock's resilience, widely dismissing a recent analyst downgrade as market manipulation to facilitate institutional buying. The sentiment is bolstered by strong industry indicators, reinforcing SMCI's position as a key, potentially undervalued, player in AI infrastructure.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as a sharp sell-off continues, fueled by multiple analyst downgrades and concerns about increasing AI competition, especially following Apple's new creative software offering. The community is deeply divided, with many calling it a "value trap" due to AI's disruptive potential, while others see a generational buying opportunity given Adobe's strong fundamentals and cash-flow generation, arguing the fears are overstated and driven by market manipulation.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is currently a hot topic as retail investors express significant frustration over perceived stock manipulation and recent share dilution, despite strong underlying business growth. The community eagerly anticipates upcoming Q4 earnings to potentially break the stock's persistent trading range, alongside ongoing discussions about the company's strategic expansion into crypto and options.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is a hot topic as it navigates a significant stock decline, fueled by reports of its multi-billion dollar acquisition of cybersecurity firm Armis and an analyst downgrade highlighting AI competition risks. The community is divided, with many viewing it as an oversold opportunity for a fundamentally strong company actively integrating AI, while others question the broader software sector's resilience against evolving AI capabilities. This ongoing debate around AI disruption versus innovation is driving conversations and market positioning for the enterprise software leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (Protagonist) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking...

Moody Aldrich Partners LLC Sells 27,510 Shares of Protagonist Therapeutics, Inc. $PTGX

Moody Aldrich Partners LLC cut its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 16.1% in the third quarter, according to the company in its most recent filing with the...

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives Consensus Rating of "Moderate Buy" from Analysts

Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fourteen research firms that are currently covering the firm...

Exchange Traded Concepts LLC Sells 13,839 Shares of Protagonist Therapeutics, Inc. $PTGX

Exchange Traded Concepts LLC reduced its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 29.2% during the 3rd quarter, according to the company in its most recent...

Protagonist Therapeutics, Inc. $PTGX Shares Purchased by Voya Investment Management LLC

Voya Investment Management LLC raised its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 8.9% during the third quarter, according to its most recent disclosure with the SEC...

Assenagon Asset Management S.A. Decreases Stock Holdings in Protagonist Therapeutics, Inc. $PTGX

Assenagon Asset Management S.A. lowered its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 28.4% in the third quarter, according to the company in its most recent...

Protagonist Therapeutics (NASDAQ:PTGX) Hits New 1-Year High - What's Next?

Protagonist Therapeutics (NASDAQ:PTGX) Reaches New 1-Year High - Time to Buy...

Protagonist Therapeutics, Inc. $PTGX Shares Purchased by BVF Inc. IL

BVF Inc. IL increased its stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 24.7% during the second quarter, according to the company in its most recent disclosure with...

683 Capital Management LLC Reduces Stake in Protagonist Therapeutics, Inc. $PTGX

683 Capital Management LLC lowered its stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 11.0% in the second quarter, according to its most recent disclosure with the...

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $803,000 Position in Protagonist Therapeutics, Inc. $PTGX

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 56.4% in the 2nd quarter, according to its...

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Current Price	$82.21
Prev Close	$84.75
Open	$84.51
Dividend Yield	0.00%
50-Day Moving Average	$85.99
Beta	0.44
Avg. Volume	941,112.14
PE Ratio	133.80

52-Week High	$96.54
52-Week Low	$33.70
Market Capitalization	$5.3B
EPS (Annual)	$4.23
Price to Book	8.20
Revenue Per Employee	$3.45M
Enterprise Value/EBITDA	N/A

PTGX
Protagonist Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PTGX News

PTGXProtagonist Therapeutics Inc